Drug Utilization Review

  1. Law
  2. Indiana Code
  3. Human Services
  4. Medicaid
  5. Drug Utilization Review

Checkout our iOS App for a better way to browser and research.

Section
12-15-35-1

"Appropriate and Medically Necessary" Defined

Section
12-15-35-2

"Board" Defined

Section
12-15-35-3

"Compendia" Defined

Section
12-15-35-4

"Counseling" Defined

Section
12-15-35-4.5

"Covered Outpatient Drug" Defined

Section
12-15-35-5

"Criteria" Defined

Section
12-15-35-6

"Drug-Disease Contraindication" Defined

Section
12-15-35-7

"Drug-Drug Interaction" Defined

Section
12-15-35-8

"Drug Utilization Review" or "Dur" Defined

Section
12-15-35-9

"Intervention" Defined

Section
12-15-35-10

"Overutilization or Underutilization" Defined

Section
12-15-35-11

"Pharmacist" Defined

Section
12-15-35-12

"Physician" Defined

Section
12-15-35-13

"Prospective Dur" Defined

Section
12-15-35-14

"Retrospective Dur" Defined

Section
12-15-35-15

"Standards" Defined

Section
12-15-35-16

"Surs" Defined

Section
12-15-35-17

"Therapeutic Appropriateness" Defined

Section
12-15-35-17.5

"Therapeutic Classification" or "Therapeutic Category" Defined

Section
12-15-35-18

"Therapeutic Duplication" Defined

Section
12-15-35-18.5

Application of Chapter

Section
12-15-35-18.7

Formulary Requirements

Section
12-15-35-19

Drug Utilization Review Board; Establishment

Section
12-15-35-20

Membership of Board

Section
12-15-35-20.1

Conflicts of Interest

Section
12-15-35-20.5

Therapeutics Committee Established; Members; Limitations; Terms; Votes; Meetings

Section
12-15-35-21

Board; Appointment; Term

Section
12-15-35-22

Qualifications of Board Members

Section
12-15-35-23

Physician Appointments; Geographic Balance

Section
12-15-35-24

Reappointment of Members

Section
12-15-35-25

Chairman; Compensation; Expenses

Section
12-15-35-26

Additional Staff

Section
12-15-35-27

Retrospective and Prospective Dur Program Responsibility

Section
12-15-35-28

Duties of the Board; Preferred Drug List; Report

Section
12-15-35-28.5

Therapeutics Committee Duties

Section
12-15-35-28.7

Submitting Initial Preferred Drug List; Limitations on Restrictions; Advance Notice to Providers; Implementation; Prior Authorization Limitation; Rules

Section
12-15-35-29

Quorum; Majority Vote on Dur Criteria and Standards for Prescribing

Section
12-15-35-30

Local Practices; Monitoring

Section
12-15-35-31

Intervention; Approval; Requisites

Section
12-15-35-32

Repealed

Section
12-15-35-32.1

Annual Report Contents

Section
12-15-35-33

Repealed

Section
12-15-35-34

Confidential Identifying Information; Release of Cumulative Nonidentifying Information

Section
12-15-35-35

Prior Approval Program for Outpatient Drugs; Standards

Section
12-15-35-36

Advisory Committees

Section
12-15-35-37

Medicaid State Plan; Inclusion of Retrospective and Prospective Dur Program

Section
12-15-35-38

Dur Program Guidelines and Procedures

Section
12-15-35-39

Retrospective Dur Requisites

Section
12-15-35-40

Prospective Dur Requisites

Section
12-15-35-41

Board Activities Under Ic 34-30-15

Section
12-15-35-42

Meetings

Section
12-15-35-43

Confidentiality; Pharmacist Data and Information

Section
12-15-35-43.5

Prohibiting the Release of Proprietary or Confidential Information Obtained Under Certain Circumstances

Section
12-15-35-44

Confidentiality; Violations; Penalty

Section
12-15-35-45

Outpatient Drug Formulary; Requirements

Section
12-15-35-46

Review of Proposed Formulary

Section
12-15-35-47

Review of Changes to Formulary

Section
12-15-35-48

Board Review of Managed Care Organization Prescription Drug Program

Section
12-15-35-49

Information Provided by Office

Section
12-15-35-50

Maximum Allowable Cost Schedule for Drugs; Pharmacy Participation in Medicaid Program

Section
12-15-35-51

Advisory Committee; Duties; Report